Consensus on diagnosis and management of Cushing's disease: a guideline update

M Fleseriu, R Auchus, I Bancos… - The lancet Diabetes & …, 2021 - thelancet.com
Cushing's disease requires accurate diagnosis, careful treatment selection, and long-term
management to optimise patient outcomes. The Pituitary Society convened a consensus …

Diagnosis and management of pituitary adenomas: a review

NA Tritos, KK Miller - Jama, 2023 - jamanetwork.com
Importance Pituitary adenomas are neoplasms of the pituitary adenohypophyseal cell
lineage and include functioning tumors, characterized by the secretion of pituitary hormones …

Current and future advances in surgical therapy for pituitary adenoma

DZ Khan, JG Hanrahan, SE Baldeweg… - Endocrine …, 2023 - academic.oup.com
The vital physiological role of the pituitary gland, alongside its proximity to critical
neurovascular structures, means that pituitary adenomas can cause significant morbidity or …

New types of localization methods for adrenocorticotropic hormone-dependent Cushing's syndrome

R Senanayake, D Gillett, J MacFarlane… - Best Practice & …, 2021 - Elsevier
The management of endogenous Cushing's syndrome (CS) typically involves two key
steps:(i) confirmation of autonomous hypercortisolism and (ii) localization of the cause to …

[HTML][HTML] Endoscopic surgery for pituitary tumors

WR Van Furth, F De Vries, DJ Lobatto… - Endocrinology and …, 2020 - endo.theclinics.com
Endoscopic Surgery for Pituitary Tumors - Endocrinology and Metabolism Clinics Skip to Main
Content Skip to Main Menu Advertisement Endocrinology and Metabolism Clinics Log in …

[HTML][HTML] Neuro-ophthalmic evaluation and management of pituitary disease

MTM Wang, JA Meyer, HV Danesh-Meyer - Eye, 2024 - nature.com
Neuro-ophthalmic evaluation is a crucial component of the diagnostic and prognostic
assessment of pituitary disease and compressive chiasmopathy, and can inform the timing …

[HTML][HTML] The clinical outcomes of imaging modalities for surgical management Cushing's disease–A systematic review and meta-analysis

CH Koh, DZ Khan, R Digpal… - Frontiers in …, 2023 - frontiersin.org
Introduction Cushing's disease presents major diagnostic and management challenges.
Although numerous preoperative and intraoperative imaging modalities have been …

Pituitary incidentaloma

SM Constantinescu, D Maiter - La Presse Médicale, 2021 - Elsevier
Pituitary incidentalomas (PI) are lesions of the pituitary region discovered fortuitously by
imaging for reasons unrelated to pituitary disease. They range from small cysts to large …

[HTML][HTML] Pituitary tumor centers of excellence for Cushing's disease

M Couselo, S Frara, A Giustina, FF Casanueva - Pituitary, 2022 - Springer
Pituitary tumors are more frequent than commonly thought [1, 2]. Despite the significant
progress of pituitary sciences in the last years, some pituitary adenomas still present …

Growth hormone receptor antagonist pegvisomant and its role in the medical therapy of growth hormone excess

J MacFarlane, M Korbonits - … Practice & Research Clinical Endocrinology & …, 2024 - Elsevier
Pegvisomant is a growth-hormone (GH) receptor antagonist that prevents the formation of
the active heterotrimer of the dimerised GH receptor and the GH molecule necessary for …